Ultra Technekow Fm

Ultra Technekow FM is a radiopharmaceutical containing Technetium (99mTc) for intravenous diagnostic imaging. Used in nuclear medicine, it helps visualize organs and blood flow. Commonly prescribed for scans like bone, heart, or thyroid imaging. Short half-life ensures rapid clearance from the body.

Technetium (99mTc) is a radioactive tracer used in nuclear medicine imaging to assess organ function and detect abnormalities. It is commonly used for bone scans to identify fractures, infections, or cancers, as well as cardiac scans to evaluate blood flow and heart function. Thyroid scans also utilize this tracer to examine gland activity and detect nodules. The imaging helps healthcare providers diagnose conditions without invasive procedures.

After intravenous administration, Technetium (99mTc) distributes through the body and emits gamma rays detectable by a gamma camera. Patients may experience mild warmth at the injection site or a metallic taste temporarily. The tracer is quickly cleared from the body, primarily through urine, with minimal discomfort reported. Some individuals may feel slight dizziness or fatigue post-procedure.

Patients should inform their healthcare provider of allergies, pregnancy, or breastfeeding status before receiving Technetium (99mTc). Avoid close contact with infants or pregnant individuals for 24 hours post-injection due to radiation exposure. Hydration before and after the scan helps facilitate tracer clearance. Follow medical staff instructions carefully to minimize radiation risk.

No known drug interactions exist with Technetium (99mTc) itself, but certain medications or recent imaging studies may affect scan results. Avoid iodine supplements or thyroid medications unless directed by a doctor. Alcohol and caffeine do not interact but may impact imaging quality for cardiac scans. Always disclose all medications and supplements to the healthcare provider.